Avatar

The Future of CAR T Therapies in Myeloma in 2018

By Nina Shah 3 Videos
06/2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
The University of Kansas Cancer Center

Hematology & Medical Oncology Review 2019

Sat, Jun 29, 2019
Multinational Association of Supportive Care in Cancer

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Fri, Jun 21, 2019
13:22
Parameswaran Hari

CAR T and NK Cell Therapy in Myeloma

08:14
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
25:50
The University of Kansas Cancer Center

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
15:01
Krina Patel

Clinical Trials in Myeloma in 2018

09:49
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...

10:29
Society of Hematologic Oncology Sixth Annual Meeting

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...

Feat. S. Jagannath
19:40
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

12:31
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:46
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
15:09
Krina Patel

Developing CAR T-cells in Multiple Myeloma

15:10
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

15:30
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available

13:29
Helen Heslop

CAR T-cell Therapy for Hematologic Malignancies Other Than CD19

09:45
2018 Pan Pacific Lymphoma Conference

CAR T-cell Toxicities and Team Management

Feat. S. Blumel
10:37
Krina Patel

How Do We Make Responses Durable in Multiple Myeloma?

17:57
City of Hope

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!

Feat. J. Mikhael
06:22
Parameswaran Hari

Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...

09:00
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma

17:46
Dana-Farber Cancer Institute

Relapse Refractory Myeloma and Novel Treatments

Feat. N. Raje
33:58
Roswell Park Comprehensive Cancer Center

Minimal Residual Disease (MRD) Testing in Multiple Myeloma. How and When...

Feat. P. McCarthy